Biondo Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.1M Sell
24,929
-220
-0.9% -$97.9K 1.46% 24
2025
Q1
$12.2M Sell
25,149
-131
-0.5% -$63.5K 1.73% 21
2024
Q4
$10.2M Buy
25,280
+185
+0.7% +$74.5K 1.4% 26
2024
Q3
$11.7M Buy
25,095
+665
+3% +$309K 1.6% 23
2024
Q2
$11.5M Buy
24,430
+23,765
+3,574% +$11.1M 1.7% 17
2024
Q1
$278K Hold
665
0.04% 83
2023
Q4
$271K Hold
665
0.05% 71
2023
Q3
$231K Sell
665
-100
-13% -$34.8K 0.04% 77
2023
Q2
$269K Hold
765
0.05% 73
2023
Q1
$241K Buy
+765
New +$241K 0.05% 73
2021
Q2
Sell
-32,026
Closed -$6.88M 88
2021
Q1
$6.88M Sell
32,026
-37,342
-54% -$8.02M 1.37% 23
2020
Q4
$16.4M Buy
69,368
+5,430
+8% +$1.28M 3.14% 8
2020
Q3
$17.4M Sell
63,938
-915
-1% -$249K 3.77% 7
2020
Q2
$18.8M Sell
64,853
-265
-0.4% -$76.9K 4.75% 5
2020
Q1
$15.5M Sell
65,118
-1,552
-2% -$369K 5.13% 4
2019
Q4
$14.6M Buy
66,670
+15,040
+29% +$3.29M 3.37% 8
2019
Q3
$8.75M Sell
51,630
-4,220
-8% -$715K 2.24% 13
2019
Q2
$10.2M Buy
55,850
+900
+2% +$165K 2.43% 10
2019
Q1
$10.1M Buy
54,950
+8,930
+19% +$1.64M 2.54% 11
2018
Q4
$7.63M Buy
46,020
+3,715
+9% +$616K 2.3% 12
2018
Q3
$8.15M Buy
42,305
+7,785
+23% +$1.5M 1.94% 14
2018
Q2
$5.87M Buy
34,520
+545
+2% +$92.6K 1.48% 20
2018
Q1
$5.54M Buy
33,975
+4,720
+16% +$769K 1.44% 24
2017
Q4
$4.38M Buy
29,255
+180
+0.6% +$27K 1.11% 30
2017
Q3
$4.42M Buy
29,075
+26,075
+869% +$3.96M 1.22% 25
2017
Q2
$387K Buy
+3,000
New +$387K 0.11% 69
2016
Q4
Sell
-43,612
Closed -$3.8M 80
2016
Q3
$3.8M Buy
+43,612
New +$3.8M 1.29% 27